This article provides researchers, scientists, and drug development professionals with a detailed examination of the JAK-STAT signaling pathway activation process.
This article provides a comprehensive guide for researchers, scientists, and drug development professionals on implementing robust intravenous (IV) to oral (PO) antimicrobial switch therapy protocols.
This detailed guide provides drug development professionals with a current, in-depth analysis of ICH stability testing guidelines for new drug substances.
This article provides a comprehensive guide to ICH Q1B photostability testing for drug development professionals, differentiating between forced degradation (stress) and confirmatory studies.
This comprehensive guide provides drug development professionals with a detailed breakdown of the ICH Q1A(R2) stability data package requirements for drug registration.
This article provides a detailed overview of the proposed ICH Q1A(R3)/Q1B(R2)/Q1C(R2) 2025 draft guidelines for stability testing of new drug substances and products.
This comprehensive guide outlines critical strategies for confirming hits from high-throughput screening (HTS) campaigns while mitigating false positives.
This comprehensive guide for researchers and drug development professionals demystifies the critical steps of normalization and error correction in High-Throughput Screening (HTS).
This comprehensive guide details the application of HTRF® (Homogeneous Time-Resolved Fluorescence) technology for high-throughput screening and mechanistic studies of cannabinoid receptors CB1R and CB2R.
This comprehensive guide explores the critical decision between High-Performance Liquid Chromatography (HPLC) and Ultra-Performance Liquid Chromatography (UPLC) for resolving complex drug mixtures in pharmaceutical research and development.